Health·2,848 stories
The Guardian's Science Weekly podcast examines whether home red-light therapy masks, wraps, and mittens actually deliver on their anti-aging and acne-reduction promises, with a consultant dermatologis
Eli Lilly is expanding its pipeline beyond GLP‑1 drugs by acquiring three early‑ and mid‑stage vaccine developers—Curevo, LimmaTech Biologics and Vaccine Company—for a combined price of nearly $4 bill
Scientists unveiled a wearable ultrasound patch that can continuously image fetuses and monitor blood flow, offering a proof‑of‑concept that may improve early detection of pregnancy complications and
US start-up Paterna Biosciences says it can turn testicular stem cells into functional sperm in the lab and has used them to fertilize human eggs into early embryos — but has published no evidence, an
The Trump administration broke with tradition by naming Florida attorney Kyle Diamantas, a former Jones Day lobbyist for food, beverage and tobacco firms, as the FDA’s top food official in 2025. Lacki
Peyton Greenside, CEO of AI‑driven biotech BigHat Biosciences, says machine‑learning can churn out a protein design in just 20 minutes, but the real hurdle is the costly, time‑intensive downstream tes
USC researchers have uncovered a hidden driver of Alzheimer’s brain inflammation—cPLA2—and designed experimental compounds that selectively block it. Using massive computational screening, they identi
A major BMJ meta-analysis pooling 12 long-term studies from the US, Europe, and Asia found that people eating the most legumes were 16% less likely to develop hypertension, with soy foods tied to a 19
Physicists are turning the traditional quest for quantum gravity on its head, suggesting that reshaping quantum mechanics to accommodate gravity may be the right path. New laboratory experiments—rangi
NIH researchers discovered that semaglutide’s weight‑loss effect hinges on cAMP signaling in the brain’s area postrema, but the response varies across neurons and wanes as receptors are internalized.
Eli Lilly’s gene‑editing therapy VERVE‑102 slashed LDL cholesterol by 62% in a Phase 1 trial without serious safety issues, marking a promising step toward a one‑time heart‑disease preventer. The drug
A large international REBOOT trial found that beta‑blockers, long prescribed after uncomplicated heart attacks, do not lower mortality or recurrent events in patients with preserved heart function, an
Researchers at Hokkaido University found that the route by which a cell ends up with doubled DNA—either cytokinesis failure or mitotic slippage—determines whether it remains viable or dies. This disti
Researchers at the University of Alabama in Huntsville and NASA’s Marshall Space Flight Center have built a cold‑plasma “laundry gun” that sanitizes fabric by generating oxygen ions that kill microbes
An editor worries that relying on AI could rob us of the dopamine‑fueled “Aha!” moments that make insights rewarding. Neuroscientists Carola Salvi and Martin Tik show that these epiphanies trigger mid
A University of Exeter crossover trial found that drinking nitrate‑rich beetroot juice twice daily for two weeks cuts blood pressure in seniors, a benefit linked to a reshaped oral microbiome that enh
May’s second full moon on May 31, 2026 is a “blue moon” under the common calendar‑month rule, but not under the stricter seasonal definition. The discrepancy arises because a lunar month is 29.5 days,
Inc42 unveiled three new hands‑on programs targeting India's fast‑growing direct‑to‑consumer sector. The 12‑week D2CX aims to help founders multiply their brand growth, while ManagementX offers a six‑
London’s Zoological Society is cooling its big cats with frozen blood‑based ice blocks while using misting fans and mud wallows, and Chester Zoo highlights natural tactics like wrist‑licking wallabies
Early SpaceX investor Chad Anderson says the next-generation Starship V3 rocket is the foundation enabling SpaceX's $1.7 trillion valuation, unlocking Starlink expansion, orbital data centers, and a M
Curated health stories, every morning. Free.
No spam. Unsubscribe anytime.